Back to top

N4 Pharma has acquired the exclusive rights to commercialise two patent applications for its vaccines division. The first concerns novel silica nano particles for certain sub-unit vaccines used for a number of diseases, including Hepatitis B, for which N4 Pharma has registered the trademark Nuvac® in the UK. The second concerns the delivery of DNA and mRNA vaccines, for which N4 Pharma has registered the trademark Nuvec® in the UK.